CENTRAL SURGERY
CORPORATION STREET, RUGBY
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 46 | 62 | 74.2% | |
| HF 4 | 2011 | 50 | 61 | 82.0% | |
| HF 4 | 2012 | 51 | 66 | 77.3% | |
| HF 4 | 2013 | 49 | 64 | 76.6% | |
| HF004 | 2014 | 46 | 50 | 92.0% | |
| HF004 | 2015 | 41 | 53 | 77.4% | |
| HF004 | 2016 | 40 | 47 | 85.1% | |
| HF004 | 2017 | 46 | 54 | 85.2% | |
| HF004 | 2018 | 56 | 62 | 90.3% | |
| HF004 | 2019 | 65 | 65 | 100.0% | |
| HF004 | 2020 | 63 | 71 | 88.7% | |
| HF006 | 2021 | 70 | 80 | 87.5% | |
| HF006 | 2022 | 72 | 86 | 83.7% | |
| HF006 | 2023 | 74 | 77 | 96.1% |
